pitchstudy

PITCH Study: Protective Immunity from T Cells in Healthcare workers is a @DHSC funded study in Oxford, Newcastle, Liverpool, Birmingham & Sheffield

[pitchstudy @pitchstudy]

Great to have our work on immune response after extended dosing interval for Pfizer BNT162b2 now formally out in peer review in Cell. Here's a 🧵from 1 of the paper's 1st authors outlining the paper. Great teamwork from the many involved - see end of thread for collaborators 👋

[Carroll Lab @Carroll_Lab_Ox]

1/ Proud to be part of this @pitchstudy ‘Immunogenicity of standard and extended dosing intervals of @pfizer BNT162b2 mRNA vaccine’ which is out in @CellCellPress https://t.co/Xz6n3XLjxe
Thread below 👇

[Dr Melissa Govender @DrMilly_Africa]

Late #ECI2024 post. Had the privilege of presenting some data from the #COVID19 #bivalentvaccine @pitchstudy in Dublin 2 weeks ago. #immunology #conference #Dublin

[pitchstudy @pitchstudy]

Our PITCH webinar today at 3pm! Please join

[British Society for Immunology @britsocimm]

🔬Interested in the role of #tcells in Covid immunity?

Tomorrow, @Pitchstudy will be holding a free webinar on immunity to #RSV, #flu and Covid-19 in healthcare workers.

Find our more and register to attend:https://t.co/iz065i4mLe

[Oxford Vaccine Group @OxfordVacGroup]

🌟 Exciting news! Join our study on RSV and SPN co-infection- now open in Liverpool @arcliverpool1!

Contribute to vital healthcare research!

📍 Liverpool
📅 Enrolment: Now open 🔗 https://t.co/ng01kai3MC

📍 Oxford: https://t.co/SeEFtdern7

#HealthcareResearch

[Muzlifah Haniffa @Muzz_Haniffa]

Come join our team 👇🏾👇🏾👇🏾

[Susanna Dunachie @Susannajd]

Brilliant to work with leading haematologists inc Andrew Pettitt @LivUni & @tobyeyre82 @UniofOxford on PETReA trial (follicular lymphoma) https://t.co/yRC9E6p5p5 during the pandemic to study COVID vaccine responses in this important vulnerable population, with @EleanorBarnesOx

[Susanna Dunachie @Susannajd]

Honoured to take up this role - @CGHRinfo is a centre for partnerships around the world supporting research, training and multi-directional learning to improve the health of people in resource limited settings. Proud to work with many talented people near and far.

[Michael Chew @MichaelWKChew]

Early/Mid-Career scientists - do apply for this fantastic opportunity. Funded by @wellcometrust, MODRA's vision is "to transform the landscape of health research in South Asia by building capacity, enhancing research skills, and fostering a vibrant community of researchers."

[STRAVINSKY @STRAVINSKYstudy]

Our Principal Investigator, @AlexRichter3, is #BSI23 discussing what affects how vulnerable different individuals are to #COVID19 infection

[Ellie Barnes 🚵‍♀️ @EleanorBarnesOx]

It's out! A fully funded fellowship in liver cancer (HCC) early detection - will suit a hepatologist, HPB surgeon, or oncologist with interest in HCC transformation and early detection - genomics and immune environment using state of the art techniques. https://t.co/P9wvjKpn9c

[Jennie Evans @jennieep]

Very pleased to be discussing our work with #SIRENstudy on their Participant Involvement Panel & the benefits it has brought to their research #BSI23

[Susanna Dunachie @Susannajd]

Do you think you’ve never had COVID? Our student Yanie Tayipto looked for evidence of viral exposure in healthcare workers with no COVID history in @vibrant_uk study - come see poster #356 at #BSI23 today

[Professor Alex Richter @AlexRichter3]

@SMHopkins explaining the impact and importance of the #Sirenstudy in monitoring the pandemic and informing policy @victoria_jhall @pitchstudy @vibrant_uk #BSI23

[Carroll Lab @Carroll_Lab_Ox]

We are hiring for another postdoctoral position in our group!

Interested in studying immune responses to SARS-CoV-2? More details here: https://t.co/fQ4Ok5RC3P

Applications close on the 3rd of January 2024 #postdocjobs

Please share!

[Professor Alex Richter @AlexRichter3]

Superb talk on meliodosis by @Susannajd. Sobering to think 1/3 of her patient participants survived the infection. Need for a vaccination, particularly in vulnerable diabetic patients, clearly made 👍

[Susanna Dunachie @Susannajd]

Superb plenary @bsicongress on human variability of vaccine responses with @SMHopkins @KnightGenetics @AlexRichter3 hearing about the power of @UKHSA #SIREN cohort, HLA associations and the importance of continued protection for people with immune vulnerabilities #BSI23

[Deborah Dunn-Walters 💙 @beecellnumbers]

Fantastic talk on mitochondria and T cell senescence from ⁦@DrSianH⁩ at #BSI23 in the #CARINA session.

[Susanna Dunachie @Susannajd]

Come to our DPhil Student Isabel Neale’s poster #389 at #BSI23 to see the work she is doing on developing a sensitive, scalable whole blood assay to measure T cells to SARS-CoV2 and other infections in low resource settings @CGHRinfo

[pitchstudy @pitchstudy]

Our review by PITCH investigators @rebecca37704429 Lulu Wang, @Alex_MRCDiMeN @LanceTurtle @AlexRichter3 @chrisjaduncan @Susannajd @PKlenermanLab on T cell immune memory after covid-19 and vaccination is now out! https://t.co/L29gOlYLfI

[pitchstudy @pitchstudy]

PITCH is proud to be a healthy control group for this very important and beautiful work on how liver patients across Europe respond to COVID vaccines

[Tom Marjot @tom_marjot]

Delighted to see this out in @JHepatology

Immune responses & clinical outcomes across 3 #COVID vaccine doses. Includes longitudinal assessment of T cells & Ab in #cirrhosis, LT, AIH, VLD & HC

🔗https://t.co/bmMImtnoIt

Has been a privilege to work with such an amazing🌍 team👇